Success Metrics

Clinical Success Rate

87.5%

Based on 7 completed trials

Completion Rate

88%(7/8)

Active Trials

3(21%)

Results Posted

29%(2 trials)

Terminated

1(7%)

Phase Distribution

Ph phase_4

Ph phase_1

Ph phase_2

29%

Ph not_applicable

43%

Ph phase_3

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 1Safety & dosage

1(7.7%)

Phase 2Efficacy & side effects

4(30.8%)

Phase 3Large-scale testing

1(7.7%)

Phase 4Post-market surveillance

1(7.7%)

N/ANon-phased studies

6(46.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(7)

Terminated(1)

Other(1)

Detailed Status

Completed7

Recruiting3

Not yet recruiting2

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (7.7%)

Phase 24 (30.8%)

Phase 31 (7.7%)

Phase 41 (7.7%)

N/A6 (46.2%)

Trials by Status

completed750%

not_yet_recruiting214%

recruiting321%

terminated17%

unknown17%

Recent Activity

3 active trials

Showing 5 of 14

not_yet_recruitingphase_2

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

NCT07714447

recruitingnot_applicable

Clinical Study of a Facial Cream for Rosacea

NCT07637032

completedphase_2

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

NCT06398808

completednot_applicable

Brighter Bites & UT Physicians Produce Rx Program

NCT05556070

recruitingnot_applicable

Maternal Mental Health Access - MaMa

NCT06049433

View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials

NCT07714447Phase 2

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

Not Yet Recruiting

NCT07637032Not Applicable

Clinical Study of a Facial Cream for Rosacea

Recruiting

NCT06398808Phase 2

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Completed

NCT05556070Not Applicable

Brighter Bites & UT Physicians Produce Rx Program

Completed

NCT06049433Not Applicable

Maternal Mental Health Access - MaMa

Recruiting

NCT06640738Phase 4

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Not Yet Recruiting

NCT05517135

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Recruiting

NCT04268641Not Applicable

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients

Completed

NCT02748707Phase 2

Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Unknown

NCT04804111Phase 2

Study of of URC102 to Assess the Efficacy and Safety in Gout Patients

Completed

NCT00742729Not Applicable

Increasing Colorectal Cancer Screening Among Filipino Americans

Completed

NCT00117806Not Applicable

Spinal Cord Injury Vocational Integration Program (SCI-VIP)

Completed

NCT01180062Phase 1

Safety Study of Latanoprost Slow Release Insert